Literature DB >> 20726032

Hypouricemic therapy: a novel potential therapeutic option for nonalcoholic fatty liver disease.

Cheng-Fu Xu, Chao-Hui Yu, Lei Xu, Xiao-Ying Sa, You-Ming Li.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20726032     DOI： 10.1002/hep.23798

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  14 in total

1.  Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes.

Authors:  Yea-Jin Choi; Hyun-Soo Shin; Hack Sun Choi; Joo-Won Park; Inho Jo; Eok-Soo Oh; Kang-Yo Lee; Byung-Hoon Lee; Richard J Johnson; Duk-Hee Kang
Journal:  Lab Invest       Date:  2014-08-11       Impact factor: 5.662

2.  Pharmacological agents for nonalcoholic steatohepatitis.

Authors:  Maeva Guillaume; Vlad Ratziu
Journal:  Hepatol Int       Date:  2013-11-19       Impact factor: 6.047

3.  Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey.

Authors:  Jeffrey C Sirota; Kim McFann; Giovanni Targher; Richard J Johnson; Michel Chonchol; Diana I Jalal
Journal:  Metabolism       Date:  2012-10-02       Impact factor: 8.694

4.  Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver.

Authors:  Miguel A Lanaspa; Laura G Sanchez-Lozada; Yea-Jin Choi; Christina Cicerchi; Mehmet Kanbay; Carlos A Roncal-Jimenez; Takuji Ishimoto; Nanxing Li; George Marek; Murat Duranay; George Schreiner; Bernardo Rodriguez-Iturbe; Takahiko Nakagawa; Duk-Hee Kang; Yuri Y Sautin; Richard J Johnson
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

5.  Association of the serum uric acid level with liver histology in biopsy-proven non-alcoholic fatty liver disease.

Authors:  Qian Huang; Jianhua Yu; Xiantu Zhang; Shourong Liu; Yanyan Ge
Journal:  Biomed Rep       Date:  2016-06-01

Review 6.  Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back.

Authors:  Chengfu Xu
Journal:  Hepatol Int       Date:  2015-12-15       Impact factor: 6.047

Review 7.  Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology.

Authors:  Richard J Johnson; Peter Stenvinkel; Sandra L Martin; Alkesh Jani; Laura Gabriela Sánchez-Lozada; James O Hill; Miguel A Lanaspa
Journal:  Obesity (Silver Spring)       Date:  2013-04       Impact factor: 5.002

8.  High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study.

Authors:  Chengfu Xu; Chaohui Yu; Lei Xu; Min Miao; Youming Li
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

9.  Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver.

Authors:  Miguel A Lanaspa; Laura G Sanchez-Lozada; Christina Cicerchi; Nanxing Li; Carlos A Roncal-Jimenez; Takuji Ishimoto; Myphuong Le; Gabriela E Garcia; Jeffrey B Thomas; Christopher J Rivard; Ana Andres-Hernando; Brandi Hunter; George Schreiner; Bernardo Rodriguez-Iturbe; Yuri Y Sautin; Richard J Johnson
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

Review 10.  Sugar, uric acid, and the etiology of diabetes and obesity.

Authors:  Richard J Johnson; Takahiko Nakagawa; L Gabriela Sanchez-Lozada; Mohamed Shafiu; Shikha Sundaram; Myphuong Le; Takuji Ishimoto; Yuri Y Sautin; Miguel A Lanaspa
Journal:  Diabetes       Date:  2013-10       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.